Lite Strategy, Inc. (NASDAQ: LITS) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT LITE STRATEGY, INC.

Lite Strategy, Inc. (NASDAQ: LITS)
Listen to this Section


$0.75
+0.0112 ( +1.51% ) 106.8K

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor.

Market Data


Open $0.75
Previous Close $0.74
Volume 106.8K
Market Cap $25.17M
Day Range $0.73 - $0.77
52 Week Range $0.69 - $3.23
Shares Outstanding 34.03M
Change % +1.51%
Net Change ▲ 0.0112
Insider Ownership N/A
Exchange NASDAQ
Sector
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2003
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 72 Nov 14, 2025

Latest News


× Before browsing our site, please accept our cookies policy